Combined Corticosteroid Injections and Shockwave Therapy for Sacroiliac Joint Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-75
SponsorTri-Service General Hospital
About this trial
This study aims to investigate the combined use of corticosteroid injections and ESWT for SIJ pain.
Eligibility criteria
Qualifiers
Low back pain lasting for 3 months or more
Pain VAS score of 4 or higher
Three or more positive results in sacroiliac joint provocation tests
At least 50% pain relief following ultrasound-guided sacroiliac joint injection with local anesthetic
Disqualifiers
Currently undergoing extracorporeal shockwave therapy in other areas
Suspected pain caused by other lumbar spine or hip joint conditions (e.g., lumbar spine or disc disorders, radicular pain, spondylolisthesis/disc degeneration, hip arthritis)
Presence of complex comorbidities, including trauma, systemic infections (e.g., fever, chills, night sweats), local sacroiliac joint infections, autoimmune diseases, or immunosuppression
Sacroiliac joint injection therapy received within the past 6 months
Trial design
Treatments tested in this trial
- Corticosteroids Triamcinolone Acetonide
- extracorporeal shockwave
- extracorporeal shockwave(minimum intensity)
Treatment groups
44 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov